Annual FCF
-$6.97 M
-$8.07 M-733.91%
30 April 2024
Summary:
Champions Oncology annual free cash flow is currently -$6.97 million, with the most recent change of -$8.07 million (-733.91%) on 30 April 2024. During the last 3 years, it has fallen by -$2.01 million (-40.53%). CSBR annual FCF is now -269.54% below its all-time high of $4.11 million, reached on 30 April 2022.CSBR Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
$311.00 K
+$2.02 M+118.24%
31 July 2024
Summary:
Champions Oncology quarterly free cash flow is currently $311.00 thousand, with the most recent change of +$2.02 million (+118.24%) on 31 July 2024. Over the past year, it has dropped by -$125.00 thousand (-28.67%). CSBR quarterly FCF is now -91.93% below its all-time high of $3.85 million, reached on 31 January 2022.CSBR Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$2.00 M
+$4.97 M+71.27%
31 July 2024
Summary:
Champions Oncology TTM free cash flow is currently -$2.00 million, with the most recent change of +$4.97 million (+71.27%) on 31 July 2024. Over the past year, it has increased by +$2.85 million (+58.75%). CSBR TTM FCF is now -134.09% below its all-time high of $5.88 million, reached on 31 October 2022.CSBR TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSBR Free Cash Flow Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -733.9% | -28.7% | +58.8% |
3 y3 years | -40.5% | -53.0% | +49.0% |
5 y5 years | -778.3% | -47.0% | -397.6% |
CSBR Free Cash Flow High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -269.5% | at low | -91.9% | +106.7% | -134.1% | +71.3% |
5 y | 5 years | -269.5% | at low | -91.9% | +106.7% | -134.1% | +71.3% |
alltime | all time | -269.5% | +28.5% | -91.9% | +106.7% | -134.1% | +79.5% |
Champions Oncology Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
July 2024 | - | $311.00 K(-118.2%) | -$2.00 M(-71.3%) |
Apr 2024 | -$6.97 M(-733.9%) | -$1.71 M(+63.2%) | -$6.97 M(+3.8%) |
Jan 2024 | - | -$1.04 M(-339.7%) | -$6.72 M(+38.4%) |
Oct 2023 | - | $436.00 K(-109.4%) | -$4.86 M(+86.1%) |
July 2023 | - | -$4.66 M(+220.9%) | -$2.61 M(-337.3%) |
Apr 2023 | $1.10 M(-73.3%) | -$1.45 M(-277.3%) | $1.10 M(-61.3%) |
Jan 2023 | - | $819.00 K(-69.5%) | $2.84 M(-51.6%) |
Oct 2022 | - | $2.68 M(-382.6%) | $5.88 M(+52.4%) |
July 2022 | - | -$949.00 K(-427.2%) | $3.85 M(-6.3%) |
Apr 2022 | $4.11 M(-182.9%) | $290.00 K(-92.5%) | $4.11 M(+315.9%) |
Jan 2022 | - | $3.85 M(+481.9%) | $989.00 K(-125.2%) |
Oct 2021 | - | $662.00 K(-195.8%) | -$3.93 M(-6.8%) |
July 2021 | - | -$691.00 K(-75.6%) | -$4.22 M(-15.0%) |
Apr 2021 | -$4.96 M(-824.4%) | -$2.83 M(+165.4%) | -$4.96 M(+347.0%) |
Jan 2021 | - | -$1.07 M(-386.3%) | -$1.11 M(-1781.8%) |
Oct 2020 | - | $373.00 K(-126.0%) | $66.00 K(-76.4%) |
July 2020 | - | -$1.43 M(-240.8%) | $280.00 K(-59.1%) |
Apr 2020 | $685.00 K(-33.4%) | $1.02 M(+842.6%) | $685.00 K(-408.6%) |
Jan 2020 | - | $108.00 K(-81.6%) | -$222.00 K(-133.0%) |
Oct 2019 | - | $587.00 K(-157.1%) | $673.00 K(-638.4%) |
July 2019 | - | -$1.03 M(-1026.1%) | -$125.00 K(-112.2%) |
Apr 2019 | $1.03 M(-141.9%) | $111.00 K(-88.9%) | $1.03 M(+44.0%) |
Jan 2019 | - | $1.00 M(-575.4%) | $714.00 K(+781.5%) |
Oct 2018 | - | -$211.00 K(-268.8%) | $81.00 K(-84.7%) |
July 2018 | - | $125.00 K(-161.6%) | $528.00 K(-121.5%) |
Apr 2018 | -$2.46 M(-31.9%) | -$203.00 K(-154.9%) | -$2.46 M(+0.7%) |
Jan 2018 | - | $370.00 K(+56.8%) | -$2.44 M(-33.0%) |
Oct 2017 | - | $236.00 K(-108.3%) | -$3.64 M(-9.1%) |
July 2017 | - | -$2.86 M(+1428.3%) | -$4.01 M(+11.1%) |
Apr 2017 | -$3.61 M(-46.4%) | -$187.00 K(-77.6%) | -$3.61 M(-12.5%) |
Jan 2017 | - | -$834.00 K(+546.5%) | -$4.12 M(-0.6%) |
Oct 2016 | - | -$129.00 K(-94.7%) | -$4.14 M(-37.3%) |
July 2016 | - | -$2.46 M(+250.4%) | -$6.61 M(-1.7%) |
Apr 2016 | -$6.73 M(-31.0%) | -$701.00 K(-18.3%) | -$6.73 M(-16.6%) |
Jan 2016 | - | -$858.00 K(-67.0%) | -$8.07 M(-15.9%) |
Oct 2015 | - | -$2.60 M(+1.0%) | -$9.60 M(+1.1%) |
July 2015 | - | -$2.57 M(+25.9%) | -$9.50 M(-2.6%) |
Apr 2015 | -$9.75 M(+165.9%) | -$2.04 M(-14.4%) | -$9.75 M(+27.4%) |
Jan 2015 | - | -$2.39 M(-4.4%) | -$7.65 M(+9.2%) |
Oct 2014 | - | -$2.50 M(-11.5%) | -$7.01 M(+62.8%) |
July 2014 | - | -$2.82 M(-5229.1%) | -$4.30 M(+17.4%) |
Apr 2014 | -$3.67 M(-15.9%) | $55.00 K(-103.2%) | -$3.67 M(-25.4%) |
Jan 2014 | - | -$1.74 M(-946.6%) | -$4.91 M(+30.9%) |
Oct 2013 | - | $206.00 K(-109.4%) | -$3.75 M(-20.4%) |
July 2013 | - | -$2.18 M(+83.2%) | -$4.72 M(+8.2%) |
Apr 2013 | -$4.36 M(-24.1%) | -$1.19 M(+103.8%) | -$4.36 M(-9.9%) |
Jan 2013 | - | -$585.00 K(-22.7%) | -$4.84 M(-0.8%) |
Oct 2012 | - | -$757.00 K(-58.5%) | -$4.88 M(-17.9%) |
July 2012 | - | -$1.82 M(+9.2%) | -$5.94 M(+3.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Apr 2012 | -$5.75 M(+4033.8%) | -$1.67 M(+167.8%) | -$5.75 M(+23.0%) |
Jan 2012 | - | -$624.00 K(-65.7%) | -$4.67 M(+96.3%) |
Oct 2011 | - | -$1.82 M(+11.7%) | -$2.38 M(+81.2%) |
July 2011 | - | -$1.63 M(+173.5%) | -$1.31 M(+844.6%) |
Apr 2011 | -$139.00 K(-93.6%) | -$596.00 K(-135.7%) | -$139.00 K(-109.8%) |
Jan 2011 | - | $1.67 M(-320.9%) | $1.42 M(-215.4%) |
Oct 2010 | - | -$755.00 K(+65.6%) | -$1.23 M(-22.0%) |
July 2010 | - | -$456.00 K(-147.3%) | -$1.58 M(-27.7%) |
Apr 2010 | -$2.18 M(+115.4%) | $964.00 K(-198.0%) | -$2.18 M(-46.4%) |
Jan 2010 | - | -$984.00 K(-10.7%) | -$4.08 M(+62.7%) |
Oct 2009 | - | -$1.10 M(+3.8%) | -$2.50 M(+35.0%) |
July 2009 | - | -$1.06 M(+14.4%) | -$1.85 M(+82.9%) |
Apr 2009 | -$1.01 M(-236.1%) | -$928.00 K(-258.1%) | -$1.01 M(-1184.5%) |
Jan 2009 | - | $587.10 K(-229.9%) | $93.50 K(-49.3%) |
Oct 2008 | - | -$452.10 K(+104.6%) | $184.40 K(-62.8%) |
July 2008 | - | -$221.00 K(-223.1%) | $495.40 K(-37.4%) |
Apr 2008 | $745.00 K(-1049.0%) | $179.50 K(-73.5%) | $792.00 K(+33.0%) |
Jan 2008 | - | $678.00 K(-580.5%) | $595.50 K(-657.6%) |
Oct 2007 | - | -$141.10 K(-286.6%) | -$106.80 K(-771.7%) |
July 2007 | - | $75.60 K(-544.7%) | $15.90 K(-120.3%) |
Apr 2007 | -$78.50 K(-16.5%) | -$17.00 K(-30.0%) | -$78.50 K(-4.3%) |
Jan 2007 | - | -$24.30 K(+32.1%) | -$82.00 K(+0.5%) |
Oct 2006 | - | -$18.40 K(-2.1%) | -$81.60 K(-5.0%) |
July 2006 | - | -$18.80 K(-8.3%) | -$85.90 K(-8.6%) |
Apr 2006 | -$94.00 K(+164.0%) | -$20.50 K(-14.2%) | -$94.00 K(+126.0%) |
Jan 2006 | - | -$23.90 K(+5.3%) | -$41.60 K(+74.1%) |
Oct 2005 | - | -$22.70 K(-15.6%) | -$23.90 K(-66.1%) |
July 2005 | - | -$26.90 K(-184.3%) | -$70.60 K(+98.3%) |
Apr 2005 | -$35.60 K(-49.6%) | $31.90 K(-614.5%) | -$35.60 K(+28.5%) |
Jan 2005 | - | -$6200.00(-91.1%) | -$27.70 K(-52.4%) |
Oct 2004 | - | -$69.40 K(-956.8%) | -$58.20 K(+67.2%) |
July 2004 | - | $8100.00(-79.6%) | -$34.80 K(-50.7%) |
Apr 2004 | -$70.60 K(-72.6%) | $39.80 K(-208.4%) | -$70.60 K(-36.7%) |
Jan 2004 | - | -$36.70 K(-20.2%) | -$111.60 K(-35.9%) |
Oct 2003 | - | -$46.00 K(+66.1%) | -$174.20 K(-25.2%) |
July 2003 | - | -$27.70 K(+2208.3%) | -$232.90 K(-9.5%) |
Apr 2003 | -$257.30 K(+446.3%) | -$1200.00(-98.8%) | -$257.30 K(+111.1%) |
Jan 2003 | - | -$99.30 K(-5.2%) | -$121.90 K(+5.4%) |
Oct 2002 | - | -$104.70 K(+101.0%) | -$115.60 K(+32.0%) |
July 2002 | - | -$52.10 K(-138.8%) | -$87.60 K(+86.0%) |
Apr 2002 | -$47.10 K(-142.4%) | $134.20 K(-244.3%) | -$47.10 K(-158.0%) |
Jan 2002 | - | -$93.00 K(+21.3%) | $81.20 K(+19.2%) |
Oct 2001 | - | -$76.70 K(+561.2%) | $68.10 K(-27.9%) |
July 2001 | - | -$11.60 K(-104.4%) | $94.40 K(-14.9%) |
Apr 2001 | $111.00 K(-449.1%) | $262.50 K(-347.4%) | $110.90 K(-173.2%) |
Jan 2001 | - | -$106.10 K(+110.5%) | -$151.60 K(+233.2%) |
Oct 2000 | - | -$50.40 K(-1128.6%) | -$45.50 K(-1028.6%) |
July 2000 | - | $4900.00 | $4900.00 |
Apr 2000 | -$31.80 K | - | - |
FAQ
- What is Champions Oncology annual free cash flow?
- What is the all time high annual FCF for Champions Oncology?
- What is Champions Oncology annual FCF year-on-year change?
- What is Champions Oncology quarterly free cash flow?
- What is the all time high quarterly FCF for Champions Oncology?
- What is Champions Oncology quarterly FCF year-on-year change?
- What is Champions Oncology TTM free cash flow?
- What is the all time high TTM FCF for Champions Oncology?
- What is Champions Oncology TTM FCF year-on-year change?
What is Champions Oncology annual free cash flow?
The current annual FCF of CSBR is -$6.97 M
What is the all time high annual FCF for Champions Oncology?
Champions Oncology all-time high annual free cash flow is $4.11 M
What is Champions Oncology annual FCF year-on-year change?
Over the past year, CSBR annual free cash flow has changed by -$8.07 M (-733.91%)
What is Champions Oncology quarterly free cash flow?
The current quarterly FCF of CSBR is $311.00 K
What is the all time high quarterly FCF for Champions Oncology?
Champions Oncology all-time high quarterly free cash flow is $3.85 M
What is Champions Oncology quarterly FCF year-on-year change?
Over the past year, CSBR quarterly free cash flow has changed by -$125.00 K (-28.67%)
What is Champions Oncology TTM free cash flow?
The current TTM FCF of CSBR is -$2.00 M
What is the all time high TTM FCF for Champions Oncology?
Champions Oncology all-time high TTM free cash flow is $5.88 M
What is Champions Oncology TTM FCF year-on-year change?
Over the past year, CSBR TTM free cash flow has changed by +$2.85 M (+58.75%)